Chronic Kidney Disease study: In-Person Patient Education vs Written Patient Education
Official title Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
ClinicalTrials.gov ID: NCT06397456
What this study is testing
- What it's testing
- The study aims to see whether an intensive referral, education, and self‑management program improves outcomes compared with enhanced usual care.
- Who it's for
- Hospitalized African American adults who have advanced chronic kidney disease.
- What's involved
- Participants are randomly assigned to receive either the 12‑week intensive program (education, navigation help, and self‑management support) or enhanced usual care.
- Time commitment
- The study lasts about 12 weeks and includes regular visits or contacts throughout that period.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patients over the age of 18 and under 70
- Admitted to the University of Chicago inpatient general medicine service
- Likely hospital stay greater than 48 hours
- Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR\<45 during admission and from previous medical...
- Self-identify as Black or African American
You likely can't join if
- Non-English speaking
- Unable to communicate due to current medical status
- Unable to consent due to mental status
- Expected hospital stay less than 24 hour
- Current admission in ICU
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.